Please use this identifier to cite or link to this item: http://rdcb.cbg.ipn.mx/handle/20.500.12273/65
Title: Association of ABCB1, ABCC5 and xanthine oxidase genetic polymorphisms with methotrexate adverse reactions in Mexican pediatric patients with ALL
Author: FAUSTO LEONARDO ZARUMA TORRES
Author ID: info:eu-repo/dai/mx/cvu/489301
Abstract: Acute lymphoblastic leukemia (ALL) is one of the most frequent oncological disorders in pediatric populations. To date, the drug of choice for the treatment of ALL is methotrexate, a drug associated with a high risk of adverse reactions (ADRs). The xanthine oxidase (XO) polymorphisms, 1936A > G and 2107A > G, as well as the polymorphic variants derived from ATP-binding cassette transporter gene subfamilies, ABCB1 and ABCC5, of drug resistant codifying genes, are implicated as precursors of drug-related neurologic, hepatic, and renal toxicities. Our aim was to determine whether the mentioned polymorphisms are risk or protective factors for the development of adverse reactions by methotrexate in our pediatric population with ALL.
Issue Date: Sep-2015
Publisher: De Gruyter
License: http://creativecommons.org/licenses/by-nc/4.0
URI: http://rdcb.cbg.ipn.mx/handle/20.500.12273/65
Language: eng
Appears in Collections:Artículos Científicos

Files in This Item:
File Description SizeFormat 
Fausto Zaruma Torres 2015 (2).pdfAssociation of ABCB1, ABCC5 and xanthine oxidase genetic polymorphisms with methotrexate adverse reactions in Mexican pediatric patients with ALL441.46 kBAdobe PDFView/Open


Items in RI-CBGIPN are protected by copyright, with all rights reserved, unless otherwise indicated.